Hans Peter Bertsch - Concepedia

Author

Hans Peter Bertsch

Also Known As

H Bertsch, H P Bertsch, H. Bertsch, H. P. Bertsch, H.-P Bertsch, H.-P. Bertsch, H.P. Bertsch, HANS PETER BERTSCH, Hans Bertsch, Hans P Bertsch

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Göttingen University of Cologne Medizinische Hochschule Hannover University of Würzburg Nephrologisches Zentrum Goettingen

About

Hans Peter Bertsch is an author at University of Göttingen specializing in medicine, dermatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	739
2	Health Sciences	6	6	294
3	Cell Biology	3	3	55
4	Family Medicine	1	1	18
5	Hepatology	1	1	21

Hans Peter Bertsch

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Results from an Observational Trial: Digital Epiluminescence Microscopy Follow-Up of Atypical Nevi Increases the Sensitivity and the Chance of Success of Conventional Dermoscopy in Detecting Melanoma Holger A. Haenssle, Ullrich Krueger, Claudia Vente, Journal of Investigative Dermatology Dermoscopic ImageDetecting MelanomaSkin CancerMedical ImagingMicroscopy	2006	141
Follicular mycosis fungoides. A histopathologic analysis of nine cases Michael J. Flaig, Lorenzo Cerroni, Kathrin Schuhmann, Journal of Cutaneous Pathology	2001	97
Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas Holger A. Haenssle, Nerjes Mograby, Anni Ngassa, JAMA Dermatology	2015	94
Chromosomal Aberration Patterns Differ in Subtypes of Primary Cutaneous B Cell Lymphomas Christian Hallermann, Kjell M. Kaune, Reiner Siebert, Journal of Investigative Dermatology Hematological MalignancyLymphoid NeoplasiaSurgical PathologyPathologyDermatology	2004	75
Results of a surveillance programme for patients at high risk of malignant melanoma using digital and conventional dermoscopy Holger A. Haenssle, Claudia Vente, Hans Peter Bertsch, European Journal of Cancer Prevention Digital PathologyDiagnosisMalignant MelanomaDermatologyOncology	2004	69
Sentinel lymph node status is the most important prognostic factor for thick (≥ 4 mm) melanomas Ralf Gutzmer, Imke Satzger, Kai‐Martin Thoms, JDDG Journal der Deutschen Dermatologischen Gesellschaft	2007	59
Factors Predicting the Risk of In-Transit Recurrence After Sentinel Lymphonodectomy in Patients With Cutaneous Malignant Melanoma Lutz Kretschmer, Iris Beckmann, Kai‐Martin Thoms, Annals of Surgical Oncology Cutaneous Malignant MelanomaSurgical OncologyMedicineCancer RecurrenceMelanoma	2006	54
Age as a key factor influencing metastasizing patterns and disease‐specific survival after sentinel lymph node biopsy for cutaneous melanoma Lutz Kretschmer, Hans Starz, Kai‐Martin Thoms, International Journal of Cancer Surgical OncologyEpidemiology Of CancerPathologyYounger AgeDermatology	2010	52
Sentinel Node Biopsy Improves Prognostic Stratification in Patients with Thin (pT1) Melanomas and an Additional Risk Factor Christina Mitteldorf, Hans Peter Bertsch, Klaus Jung, Annals of Surgical Oncology Surgical OncologyMedicineSurgical PathologyMelanomaAdditional Risk Factor	2014	46
Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomas Lutz Kretschmer, Irene K. Beckmann, K-M Thoms, European Journal of Cancer Surgical OncologyMedicineSurgical PathologyMelanomaSurgery	2005	44

Page 1